Fred Hutchinson Cancer Center
R

The Role of CSF1R in Modulating Inflammation and Fibrosis

By Fred Hutchinson Cancer Center FEATURING Rachael Adams
By Fred Hutchinson Cancer Center FEATURING Rachael Adams
24 views
September 19, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Related Content

AUTOPLAY
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

Feat. B. D. Cheson
31:53
Indy Hematology Review

HSCT in 2024: What Every Hematologist Needs to Know

Feat. R. Childs
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
19:14
SOHO Brazil 2024

FL: How Do I Deal With Relapse?

Feat. B. Kahl
13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl
06:33
Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

20:34
UChicago Medicine

Sequencing of Bispecifics With Other Therapies in DLBCL

Feat. E. Budde
27:51
Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa
16:34
Jennifer Amengual

Top 5 Lymphoma Abstracts From ASH

04:32
Yasmin Karimi

FDA Approval of Epcoritamab in R/R FL: What You Need to Know

14:34
Northwestern Medicine Oncology and Hematology

EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial

Feat. L. Gordon
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
17:07
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their…

Feat. M. Minnema
09:42
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based Gv…

Feat. M. Al Malki
18:24
Memorial Sloan Kettering Cancer Center

Key Lymphoma Updates From ASH

Feat. P. Torka
13:40
UChicago Medicine

Summary of Bispecific Antibodies for Follicular Lymphoma

Feat. D. Russler-Germain
08:28
Bruce D. Cheson

Tazemetostat in R/R FL: Impact of EZH2 Mutational Status on PFS

09:48
Erin Mulvey

Tazemetostat in Older Frail Adults With Follicular Lymphoma

25:22
Integrity CE

Treatment Updates and Management of Non-Hodgkin Lymphomas

Feat. D. Wallace, M. Cortese
19:46
Scripps Health

Management of Indolent NHL

Feat. E. Brem